Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 2
1981 1
1982 1
1984 1
1986 2
1987 1
1988 3
1989 3
1990 3
1991 3
1992 4
1993 2
1994 6
1995 10
1996 4
1997 3
1998 3
1999 8
2000 2
2001 7
2002 6
2003 3
2004 4
2005 5
2006 5
2007 4
2008 3
2009 4
2010 3
2011 5
2012 1
2013 9
2014 3
2015 1
2016 1
2017 3
2018 5
2019 7
2020 10
2021 12
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

151 results
Results by year
Filters applied: . Clear all
Page 1
Relationship between P1NP, a biochemical marker of bone turnover, and bone mineral density in patients transitioned from alendronate to romosozumab or teriparatide: a post hoc analysis of the STRUCTURE trial.
Takada J, Dinavahi R, Miyauchi A, Hamaya E, Hirama T, Libanati C, Nakamura Y, Milmont CE, Grauer A. Takada J, et al. Among authors: hirama t. J Bone Miner Metab. 2020 May;38(3):310-315. doi: 10.1007/s00774-019-01057-1. Epub 2019 Nov 9. J Bone Miner Metab. 2020. PMID: 31707465 Clinical Trial.
Protein partners of C/EBPepsilon.
Chih DY, Park DJ, Gross M, Idos G, Vuong PT, Hirama T, Chumakov AM, Said J, Koeffler HP. Chih DY, et al. Among authors: hirama t. Exp Hematol. 2004 Dec;32(12):1173-81. doi: 10.1016/j.exphem.2004.08.014. Exp Hematol. 2004. PMID: 15588942
151 results